Featured Post from Aston University

Expert reaction to the UK AI Safety Summit

Nov 1, 2023

2 min

Today the UK government announced a "world first agreement" on how to manage the riskiest forms of AI.

It focuses on so-called "frontier AI" - what ministers consider highly advanced forms of the tech - with as-yet unknown capabilities.

The agreement, signed by countries including the US, the EU and China, was announced at the UK's AI Safety Summit.



Dr Alina Patelli, Senior Lecturer in Computer Science, Aston University, comments:



“A summit on AI safety is long overdue. As is the case with all groundbreaking technologies, AI’s transformative potential for public good is only matched by its risks, which are unlikely to be successfully avoided, if AI tech design and deployment are left unregulated and therefore open to misuse, either intentionally or accidentally. The scope of the summit is appropriate, reflective of Government’s cautious approach to managing interactions with AI safety experts from multiple nations and disciplines: the summit focus is kept narrow, to five objectives only, and the number of participants is wisely limited to 100, to keep the conversation productive.”


What is likely to come out of this summit?


“The summit’s main output will most likely be a bare-bones regulatory document comprising (1) a shared understanding of AI (i.e., a generally accepted definition of the term reflective of all summit participants’ views, not just those of tech experts), (2) a list of major risks associated to AI misuse, both in terms of potential damage as well as likelihood of becoming a reality, and (3) a policy draft outlining the core elements that a yet-to-be-developed governance framework should include.”


What AI safety could/should look like?


“Although it would be premature to venture a definition of AI safety ahead of the summit, one thing that is certain is that a comprehensive, therefore effective, AI regulatory framework would encompass more than just laws. Non-legally binding codes of conduct, tech design and development processes that are bound by moral and ethical values, both in the commercial ecosystem, as well as when it comes to individual entrepreneurs, revised open-access licenses under which AI should be used in the public domain, etc. are equally important pieces. The best way to integrate all these in a cohesive, overarching governance plan is perhaps a topic to explore in one of the post-summit events.”



What are the potential practicalities for a route forward towards safe AI?


“The practical way to systematically regulate AI is incremental. Initially, the development and application of those AI tools deemed to be high-risk will most likely be restricted to controlled environments, where the potential benefits justify the risks and where sound mitigation procedures can be quickly and effectively enforced to mitigate those risks. As regulations become better prescribed, AI’s (safe and legal) application space will gradually expand, making its benefits available to larger groups of people without any of the downsides.”



To interview Dr Alina Patelli or request further details contact Nicola Jones, Press and Communications Manager, on (+44) 7825 342091 or email: n.jones6@aston.ac.uk


Powered by

You might also like...

Check out some other posts from Aston University

2 min

Medication adherence: Why it matters and how we can improve it – public lecture by Professor Ian Maidment

Professor Ian Maidment is a professor in clinical pharmacy at Aston Pharmacy School His inaugural lecture will explain why patients struggle with taking medication and present possible solutions to the problem Professor Maidment is a former practising pharmacist and an expert in medication optimisation and management in mental health and dementia. Professor Ian Maidment, professor in clinical pharmacy at Aston Pharmacy School, will give a public lecture about his life’s work on 5 February 2025. In his inaugural lecture, Professor Maidment will reflect on his journey from a childhood in Kent to becoming a leading researcher in clinical pharmacy. After more than two decades working in the NHS, in community pharmacy, mental health, dementia care, and leadership roles, he joined Aston University in 2012. His research focuses on the real-world challenges of medication optimisation for patients, carers, and healthcare professionals. The title of Professor Maidment’s lecture is ‘Medication adherence: Why it matters and how we can improve it’. Every year, the UK spends nearly £21 billion on medicines. Yet up to half of people with long-term conditions do not take their medication as prescribed—a problem known as non-adherence. This has profound clinical consequences and significant financial implications for the NHS. Professor Maidment will draw on his experience to explore how factors such as medication burden and side-effects influence adherence, the challenges posed by conditions such as dementia and severe mental illness, the role of pharmacy in supporting adherence and why tackling non-adherence requires a system-wide approach. He will also offer practical solutions to one of healthcare’s most persistent problems. Professor Maidment said: “We need to understand why patients struggle to take their medication and then develop and test solutions that work well.” The lecture on Thursday 5 February 2026 will take place at Aston Business School. In-person tickets are available from Eventbrite. The public lecture will begin at 18:00 GMT with refreshments served from 17:30 GMT. It is free of charge and will be followed by a drinks reception. The lecture will also be streamed online.

3 min

New research partnership to develop biodegradable gloves from food waste for healthcare sector

Knowledge Transfer Partnership between Aston University and PFE Medical to develop a biodegradable clinical glove from food waste The gloves will provide a low-cost, convenient and sustainable alternative to the 1.4bn disposable gloves used in the NHS each year The innovation will reduce clinical waste and costs and help the NHS reach its net zero goals. Aston University and Midlands-based company PFE Medical are teaming up to create biodegradable gloves made from food waste for use in the NHS. They will offer a low-cost, convenient alternative to disposable gloves without compromising patient safety. More than 1.4bn disposable gloves are used by the NHS each year. They create large volumes of clinical waste which has both an environmental and economic cost. The Knowledge Transfer Partnership (KTP) project will develop a more sustainable alternative made from polymers derived from food waste such as orange peel, able to degrade naturally. The gloves will initially be for use during low-risk tasks such as ultrasound scans, rather than in more critical situations such as operating theatres. The gloves would be designed to not only reduce clinical waste and costs in the NHS, but also carbon emissions, helping the NHS reach its goal to be the world’s first net-zero health service. With most personal protective equipment (PPE) currently sourced from Chinese manufacturers, the goal is to develop a biodegradable glove that can be manufactured using a UK supply chain. The challenging project draws on Aston University’s expertise in sustainable polymer chemistry, centred at Aston Institute for Membrane Excellence (AIME). Aston University has one of the largest research groups of polymer chemists in the UK. The project will be led at the University by Professor Paul Topham, director of AIME, and Dr James Wilson, AIME associate member. The research team have chosen to focus on polymers from food waste in order to ensure that the final product can be manufactured sustainably. Most polymers are currently made from petroleum. Polymers made from food waste, ranging from fruit waste to corn or dairy products, have the potential for antioxidant and antibacterial properties if designed appropriately. The team will manipulate the polymer molecules so that they include the right monomers (the smaller units which make up the molecules) in the right location to achieve the properties they require. Critical to the success of the project will be PFE Medical’s commercial and clinical experience of taking new innovations into medical use. It will be the third KTP between Aston University and PFE, following on from successful projects to develop an automated endoscope cleaner, now in use across University Hospitals Birmingham NHS Foundation Trust (UHB). Professor Topham said: “At Aston University, we have a long history of working with industry, of translating fundamental research into solutions for real world problems. This project with PFE Medical provides us with that route, to take our science and engineering and make a difference to peoples’ lives. That’s exactly where, as researchers, we want to be.” Rob Hartley, CEO of PFE Medical, said: “Our previous KTP with Aston University was a phenomenal success, thanks to the brilliant team we had on board. I’m just as excited by this project, which is looking to solve an equally long-standing problem. If we can achieve our goal, then the implications are huge, going far beyond the NHS to all the other situations where people are wearing disposable gloves.” KTPs, funded by Innovate UK, are collaborations between a business, a university and a highly qualified research associate. The UK-wide programme helps businesses to improve their competitiveness and productivity through the better use of knowledge, technology and skills. Aston University is a sector-leading KTP provider, ranked first for project quality, and joint first for the volume of active projects. For further details about this KTP, visit the webpage: www.aston.ac.uk/business/collaborate-with-us/knowledge-transfer-partnership/at-work/pfe-medical.

2 min

Aston University’s Professor Gina Rippon wins British Psychological Society book award for The Lost Girls of Autism

Gina Rippon, professor emeritus of cognitive neuroimaging at Aston University, has won an award for her book, The Lost Girls of Autism The book won the 2025 British Psychological Society Popular Science Award It explores the emerging science of female autism, and examines why it has been systematically ignored and misunderstood for so long. The Lost Girls of Autism, the latest book from Gina Rippon, professor emeritus of cognitive neuroimaging at Aston University Institute of Health and Neurodevelopment (IHN), has won the 2025 British Psychological Society (BPS) Popular Science Award. The annual BPS Book Awards recognise exceptional published works in the field of psychology. There are four categories – popular science, textbook, academic monograph and practitioner text. With the subtitle ‘How Science Failed Autistic Women and the New Research that’s Changing the Story’, The Lost Girls of Autism explores the emerging science of female autism, and examines why it has been systematically ignored and misunderstood for so long. Historically, clinicians believed that autism was a male condition, and simply did not look for it in girls and women. This has meant that autistic girls visiting a doctor have been misdiagnosed with anxiety, depression or personality disorders, or are missed altogether. Many women only discover they have the condition when they are much older. Professor Rippon said: “It's such a pleasure and an honour to receive this award from the BPS. It’s obviously flattering to join the great company of previous winners, but I’m also extremely grateful for the attention drawn to the issues raised in the book. “Over many decades, due to autism’s ‘male spotlight’ problem, autistic girls and women have been overlooked, deprived of the help they needed, and even denied access to the very research studies that could widen our understanding of autism. This book tells the stories of these girls and women, and I’m thrilled to accept this prize on their behalf.”

View all posts
Powered by